Logo image of TRS

TRIMAS CORP (TRS) Stock Fundamental Analysis

USA - NASDAQ:TRS - US8962152091 - Common Stock

38.64 USD
+0.14 (+0.36%)
Last: 9/30/2025, 8:00:01 PM
38.64 USD
0 (0%)
After Hours: 9/30/2025, 8:00:01 PM
Fundamental Rating

5

Taking everything into account, TRS scores 5 out of 10 in our fundamental rating. TRS was compared to 22 industry peers in the Containers & Packaging industry. While TRS seems to be doing ok healthwise, there are quite some concerns on its profitability. TRS has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year TRS was profitable.
TRS had a positive operating cash flow in the past year.
Of the past 5 years TRS 4 years were profitable.
In the past 5 years TRS always reported a positive cash flow from operatings.
TRS Yearly Net Income VS EBIT VS OCF VS FCFTRS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M

1.2 Ratios

The Return On Assets of TRS (2.58%) is comparable to the rest of the industry.
TRS has a Return On Equity (5.22%) which is in line with its industry peers.
With a Return On Invested Capital value of 4.16%, TRS is not doing good in the industry: 68.18% of the companies in the same industry are doing better.
The Average Return On Invested Capital over the past 3 years for TRS is below the industry average of 7.26%.
Industry RankSector Rank
ROA 2.58%
ROE 5.22%
ROIC 4.16%
ROA(3y)3.3%
ROA(5y)1.52%
ROE(3y)6.57%
ROE(5y)3.03%
ROIC(3y)4.55%
ROIC(5y)4.78%
TRS Yearly ROA, ROE, ROICTRS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 -10

1.3 Margins

Looking at the Profit Margin, with a value of 3.83%, TRS is in line with its industry, outperforming 59.09% of the companies in the same industry.
In the last couple of years the Profit Margin of TRS has declined.
TRS's Operating Margin of 6.69% is on the low side compared to the rest of the industry. TRS is outperformed by 63.64% of its industry peers.
In the last couple of years the Operating Margin of TRS has declined.
With a decent Gross Margin value of 22.59%, TRS is doing good in the industry, outperforming 72.73% of the companies in the same industry.
In the last couple of years the Gross Margin of TRS has declined.
Industry RankSector Rank
OM 6.69%
PM (TTM) 3.83%
GM 22.59%
OM growth 3Y-22.8%
OM growth 5Y-16.54%
PM growth 3Y-26.81%
PM growth 5Y-28.08%
GM growth 3Y-5.16%
GM growth 5Y-4.21%
TRS Yearly Profit, Operating, Gross MarginsTRS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20

6

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so TRS is destroying value.
The number of shares outstanding for TRS has been reduced compared to 1 year ago.
TRS has less shares outstanding than it did 5 years ago.
The debt/assets ratio for TRS is higher compared to a year ago.
TRS Yearly Shares OutstandingTRS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
TRS Yearly Total Debt VS Total AssetsTRS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

TRS has an Altman-Z score of 2.41. This is not the best score and indicates that TRS is in the grey zone with still only limited risk for bankruptcy at the moment.
TRS has a better Altman-Z score (2.41) than 81.82% of its industry peers.
TRS has a debt to FCF ratio of 13.43. This is a negative value and a sign of low solvency as TRS would need 13.43 years to pay back of all of its debts.
TRS has a Debt to FCF ratio (13.43) which is in line with its industry peers.
TRS has a Debt/Equity ratio of 0.60. This is a neutral value indicating TRS is somewhat dependend on debt financing.
With an excellent Debt to Equity ratio value of 0.60, TRS belongs to the best of the industry, outperforming 81.82% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.6
Debt/FCF 13.43
Altman-Z 2.41
ROIC/WACC0.48
WACC8.75%
TRS Yearly LT Debt VS Equity VS FCFTRS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.3 Liquidity

A Current Ratio of 2.59 indicates that TRS has no problem at all paying its short term obligations.
The Current ratio of TRS (2.59) is better than 95.45% of its industry peers.
A Quick Ratio of 1.44 indicates that TRS should not have too much problems paying its short term obligations.
TRS has a better Quick ratio (1.44) than 90.91% of its industry peers.
Industry RankSector Rank
Current Ratio 2.59
Quick Ratio 1.44
TRS Yearly Current Assets VS Current LiabilitesTRS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 10.92% over the past year.
TRS shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -0.59% yearly.
The Revenue has been growing slightly by 6.73% in the past year.
The Revenue has been growing slightly by 5.04% on average over the past years.
EPS 1Y (TTM)10.92%
EPS 3Y-9.51%
EPS 5Y-0.59%
EPS Q2Q%41.86%
Revenue 1Y (TTM)6.73%
Revenue growth 3Y2.57%
Revenue growth 5Y5.04%
Sales Q2Q%14.25%

3.2 Future

Based on estimates for the next years, TRS will show a very strong growth in Earnings Per Share. The EPS will grow by 20.17% on average per year.
Based on estimates for the next years, TRS will show a quite strong growth in Revenue. The Revenue will grow by 8.12% on average per year.
EPS Next Y24.03%
EPS Next 2Y20.17%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year10.14%
Revenue Next 2Y8.12%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
TRS Yearly Revenue VS EstimatesTRS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 500M 1B 1.5B
TRS Yearly EPS VS EstimatesTRS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5 2

4

4. Valuation

4.1 Price/Earnings Ratio

TRS is valuated rather expensively with a Price/Earnings ratio of 20.02.
TRS's Price/Earnings ratio is in line with the industry average.
TRS is valuated rather cheaply when we compare the Price/Earnings ratio to 27.76, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 16.12, TRS is valued correctly.
Based on the Price/Forward Earnings ratio, TRS is valued a bit more expensive than the industry average as 68.18% of the companies are valued more cheaply.
The average S&P500 Price/Forward Earnings ratio is at 23.18. TRS is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 20.02
Fwd PE 16.12
TRS Price Earnings VS Forward Price EarningsTRS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of TRS indicates a slightly more expensive valuation: TRS is more expensive than 68.18% of the companies listed in the same industry.
The rest of the industry has a similar Price/Free Cash Flow ratio as TRS.
Industry RankSector Rank
P/FCF 49.51
EV/EBITDA 15.14
TRS Per share dataTRS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
TRS's earnings are expected to grow with 20.17% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.83
PEG (5Y)N/A
EPS Next 2Y20.17%
EPS Next 3YN/A

3

5. Dividend

5.1 Amount

With a yearly dividend of 0.42%, TRS is not a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 3.28, TRS is paying slightly less dividend.
With a Dividend Yield of 0.42, TRS pays less dividend than the S&P500 average, which is at 2.41.
Industry RankSector Rank
Dividend Yield 0.42%

5.2 History

TRS has been paying a dividend for over 5 years, so it has already some track record.
TRS has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years3
TRS Yearly Dividends per shareTRS Yearly Dividends per shareYearly Dividends per share 2021 2022 2023 2024 2025 0.05 0.1 0.15

5.3 Sustainability

17.66% of the earnings are spent on dividend by TRS. This is a low number and sustainable payout ratio.
DP17.66%
EPS Next 2Y20.17%
EPS Next 3YN/A
TRS Yearly Income VS Free CF VS DividendTRS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M
TRS Dividend Payout.TRS Dividend Payout, showing the Payout Ratio.TRS Dividend Payout.PayoutRetained Earnings

TRIMAS CORP

NASDAQ:TRS (9/30/2025, 8:00:01 PM)

After market: 38.64 0 (0%)

38.64

+0.14 (+0.36%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryContainers & Packaging
Earnings (Last)07-29 2025-07-29/bmo
Earnings (Next)10-23 2025-10-23/bmo
Inst Owners99.48%
Inst Owner Change1.13%
Ins Owners5.87%
Ins Owner Change2.62%
Market Cap1.57B
Analysts80
Price Target40.22 (4.09%)
Short Float %9.23%
Short Ratio5.35
Dividend
Industry RankSector Rank
Dividend Yield 0.42%
Yearly Dividend0.16
Dividend Growth(5Y)N/A
DP17.66%
Div Incr Years0
Div Non Decr Years3
Ex-Date08-05 2025-08-05 (0.04)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)19.64%
Min EPS beat(2)13.72%
Max EPS beat(2)25.56%
EPS beat(4)2
Avg EPS beat(4)2.34%
Min EPS beat(4)-19.44%
Max EPS beat(4)25.56%
EPS beat(8)4
Avg EPS beat(8)-3.73%
EPS beat(12)5
Avg EPS beat(12)-4.83%
EPS beat(16)7
Avg EPS beat(16)-3.77%
Revenue beat(2)2
Avg Revenue beat(2)4.97%
Min Revenue beat(2)1.64%
Max Revenue beat(2)8.31%
Revenue beat(4)2
Avg Revenue beat(4)1.16%
Min Revenue beat(4)-5.11%
Max Revenue beat(4)8.31%
Revenue beat(8)3
Avg Revenue beat(8)-1.9%
Revenue beat(12)4
Avg Revenue beat(12)-3.33%
Revenue beat(16)4
Avg Revenue beat(16)-3.06%
PT rev (1m)0%
PT rev (3m)15.47%
EPS NQ rev (1m)0%
EPS NQ rev (3m)13.49%
EPS NY rev (1m)0%
EPS NY rev (3m)11.67%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)5.27%
Revenue NY rev (1m)0%
Revenue NY rev (3m)4.37%
Valuation
Industry RankSector Rank
PE 20.02
Fwd PE 16.12
P/S 1.61
P/FCF 49.51
P/OCF 17.73
P/B 2.2
P/tB 9.59
EV/EBITDA 15.14
EPS(TTM)1.93
EY4.99%
EPS(NY)2.4
Fwd EY6.2%
FCF(TTM)0.78
FCFY2.02%
OCF(TTM)2.18
OCFY5.64%
SpS23.96
BVpS17.6
TBVpS4.03
PEG (NY)0.83
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 2.58%
ROE 5.22%
ROCE 5.19%
ROIC 4.16%
ROICexc 4.26%
ROICexgc 7.75%
OM 6.69%
PM (TTM) 3.83%
GM 22.59%
FCFM 3.26%
ROA(3y)3.3%
ROA(5y)1.52%
ROE(3y)6.57%
ROE(5y)3.03%
ROIC(3y)4.55%
ROIC(5y)4.78%
ROICexc(3y)4.82%
ROICexc(5y)5.17%
ROICexgc(3y)9.3%
ROICexgc(5y)10.22%
ROCE(3y)5.66%
ROCE(5y)5.96%
ROICexcg growth 3Y-26.13%
ROICexcg growth 5Y-19.63%
ROICexc growth 3Y-23.76%
ROICexc growth 5Y-16.4%
OM growth 3Y-22.8%
OM growth 5Y-16.54%
PM growth 3Y-26.81%
PM growth 5Y-28.08%
GM growth 3Y-5.16%
GM growth 5Y-4.21%
F-Score6
Asset Turnover0.67
Health
Industry RankSector Rank
Debt/Equity 0.6
Debt/FCF 13.43
Debt/EBITDA 3.28
Cap/Depr 87.86%
Cap/Sales 5.84%
Interest Coverage 3.38
Cash Conversion 68.19%
Profit Quality 85.02%
Current Ratio 2.59
Quick Ratio 1.44
Altman-Z 2.41
F-Score6
WACC8.75%
ROIC/WACC0.48
Cap/Depr(3y)86.35%
Cap/Depr(5y)84.94%
Cap/Sales(3y)5.59%
Cap/Sales(5y)5.46%
Profit Quality(3y)59.07%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)10.92%
EPS 3Y-9.51%
EPS 5Y-0.59%
EPS Q2Q%41.86%
EPS Next Y24.03%
EPS Next 2Y20.17%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)6.73%
Revenue growth 3Y2.57%
Revenue growth 5Y5.04%
Sales Q2Q%14.25%
Revenue Next Year10.14%
Revenue Next 2Y8.12%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-6.89%
EBIT growth 3Y-20.81%
EBIT growth 5Y-12.34%
EBIT Next Year53.18%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y44.84%
FCF growth 3Y-47.6%
FCF growth 5Y-22.52%
OCF growth 1Y24.54%
OCF growth 3Y-21.96%
OCF growth 5Y-3.34%